Candicidin for vaginal candidiasis.
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000009:adverse effects; D003365:Costs and Cost Analysis; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D009761:Nystatin / Q000627:therapeutic use; D009824:Ointments; D010409:Penile Diseases / Q000188:drug therapy; D013607:Tablets
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D003276:Contraceptives, Oral; D009824:Ointments; D013607:Tablets; D009761:Nystatin